Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
opucolimab
(HLX20) /
Fosun Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
opucolimab
(HLX20) /
Fosun Pharma
Trial completion, Metastases:
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
(clinicaltrials.gov) - Jun 3, 2022
P1
, N=26, Completed,
Sponsor: Shanghai Henlius Biotech
Recruiting --> Completed
|
|||||||||
opucolimab
(HLX20) /
Fosun Pharma
New P1 trial, Metastases:
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
(clinicaltrials.gov) - Jul 16, 2018
P1
, N=30, Recruiting,
Sponsor: Shanghai Henlius Biotech